Drug Type Small molecule drug |
Synonyms OST 122 |
Target |
Mechanism ARK5 inhibitors(NUAK family kinase 1 inhibitors), JAK3 inhibitors(Tyrosine-protein kinase JAK3 inhibitors), TYK2 inhibitors(Tyrosine-protein kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Phase 2 | ES | 16 Sep 2020 | |
Colitis, Ulcerative | Phase 2 | UA | 16 Sep 2020 |